{"id":290045,"date":"2025-10-09T19:47:18","date_gmt":"2025-10-09T19:47:18","guid":{"rendered":"https:\/\/www.europesays.com\/us\/290045\/"},"modified":"2025-10-09T19:47:18","modified_gmt":"2025-10-09T19:47:18","slug":"health-ministry-warns-of-falsified-avastin-cancer-drug-in-kenyan-market","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/us\/290045\/","title":{"rendered":"Health Ministry warns of falsified Avastin cancer drug in Kenyan market"},"content":{"rendered":"<p> <a href=\"https:\/\/www.citizen.digital\/author\/jelilah-daud-133126\" data-v-66cb4d34=\"\" target=\"_blank\" rel=\"noopener\"><img decoding=\"async\" src=\"https:\/\/ui-avatars.com\/api\/?name=J+D&amp;color=7F9CF5&amp;background=EBF4FF\" alt=\"Jelilah Daud\" data-v-66cb4d34=\"\"\/><\/a> By<br \/>\n                  <a href=\"https:\/\/www.citizen.digital\/author\/jelilah-daud-133126\" data-v-66cb4d34=\"\" target=\"_blank\" rel=\"noopener\"><br \/>\n                    Jelilah Daud<br \/>\n                  <\/a><br \/>\n                  Published on:  October 09, 2025 04:41 (EAT)<br \/>\n                  <img decoding=\"async\" title=\"Health Ministry warns of falsified Avastin cancer drug in Kenyan market\" alt=\"Health Ministry warns of falsified Avastin cancer drug in Kenyan market\" src=\"https:\/\/www.europesays.com\/us\/wp-content\/uploads\/2025\/10\/sindano-og_image.webp.webp\" loading=\"lazy\" data-v-66cb4d34=\"\"\/>   <img decoding=\"async\" data-v-7257c9c5=\"\" src=\"https:\/\/www.europesays.com\/us\/wp-content\/uploads\/2025\/06\/tts-pre-loader.gif\" alt=\"Vocalize Pre-Player Loader\" style=\"all:unset!important;display:inline!important;\" data-v-66cb4d34=\"\"\/> <\/p>\n<p data-v-7257c9c5=\"\" style=\"font-size:13px;margin-left:20px;\" data-v-66cb4d34=\"\">Audio By Vocalize<\/p>\n<p class=\"MsoNormal\">The Ministry of Health, through the Pharmacy and Poisons Board (PPB),<br \/>\nhas identified a falsified batch of Avastin ( Bevacizumab 100 mg) injection<br \/>\nthat is currently circulating in the Kenyan market.<\/p>\n<p class=\"MsoNormal\">In a statement issued on Thursday, the Board noted that the<br \/>\nfalsified injection Batch Number H0573B01 is falsely purported to be<br \/>\nmanufactured by Roche, a company globally known for being the leading provider<br \/>\nof in-vitro diagnostics and a global supplier of transformative innovative<br \/>\nsolutions across major disease areas. <\/p>\n<p class=\"MsoNormal\">\u201cThe board hereby instructs all procurement agencies,<br \/>\ndistributors, pharmacists, pharmaceutical technologies, healthcare workers and<br \/>\nthe public to stay alert and promptly report any cases involving the falsified<br \/>\nbatch of Avastin,\u201d said Dr. A. Mohamed, the Chief Executive Officer at the<br \/>\nMinistry of Health.<\/p>\n<p class=\"MsoNormal\">Avastin (Bevacizumab 100 mg<br \/>\nInjection) is a prescription medication used in<br \/>\nthe treatment of various<br \/>\ntypes of cancer.<\/p>\n<p class=\"MsoNormal\">The government further urged all stakeholders in the supply<br \/>\nchain to source Health Products and Technologies (HPTs) exclusively from<br \/>\nlicensed manufacturers, importers, distributors and retailers, warning of the<br \/>\ndangers of obtaining products from unlicensed sources.<\/p>\n<p class=\"MsoNormal\">\u201cThe Board in collaboration with the government<br \/>\nInvestigative Agencies, will institute legal and regulatory actions against any<br \/>\nindividual or entity involved in the circulation of this falsified batch in<br \/>\nviolation of the Pharmacy and Poisons Act (CAP 244),\u201d Dr. Mohamed further said.<\/p>\n<p class=\"MsoNormal\">Meanwhile, members of the public and healthcare providers<br \/>\nhave been urged to promptly report any suspected substandard and falsified<br \/>\nmedical products.<\/p>\n","protected":false},"excerpt":{"rendered":"By Jelilah Daud Published on: October 09, 2025 04:41 (EAT) Audio By Vocalize The Ministry of Health, through&hellip;\n","protected":false},"author":3,"featured_media":290046,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[34],"tags":[148840,235,210,1060,26838,148839,67,132,68],"class_list":{"0":"post-290045","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-avastin","9":"tag-cancer","10":"tag-health","11":"tag-medication","12":"tag-ministry-of-health","13":"tag-pharmacy-and-poisons-board","14":"tag-united-states","15":"tag-unitedstates","16":"tag-us"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@us\/115345938975740293","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/290045","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=290045"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/290045\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/290046"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=290045"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=290045"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=290045"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}